Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Filed Nov 4, 2011 · 10-Q · 35 days after period end · 0001367644-11-000064
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $58.76M | $73.99M |
| Net Income | $1.55M | $13.12M |
| EPS Diluted | $0.04 | $0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 4, 2011 · 35 d after period end
